Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$29.0K
10.06K shares
What this filing means
SMALES KELLY plans to sell 10.06K shares of TRANSPHORM, INC. valued at approximately $29.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/3/2024ACC: 0001970051-24-000001
10.06K
Shares to sell
$29.0K
Approx. market value
2.19K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
1/2/2024
2.19KTotal acquired2.19K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2024 | Common Stock COMPENSATORY PAYMENT | 2.19K | — |
| Total | 2.19K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4K
Market value
$10.5K
11/22/2023
—Completed
Units to sell
656.00
Market value
$1.9K
11/20/2023
—Completed
Units to sell
3.23K
Market value
$8.8K
11/17/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.19K
Market value
$7.9K
1/2/2024
Total
Units
10.06K
Value
$29.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/22/2023 | 4K | $10.5K | — | Completed |
11/20/2023 | 656.00 | $1.9K | — | Completed |
11/17/2023 | 3.23K | $8.8K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2024 | 2.19K | $7.9K | NASDAQ | Planned |
| Total | 10.06K | $29.0K | ||